Variant report
Variant | esv1849315 |
---|---|
Chromosome Location | chr3:25025216-25031381 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:25014243..25016013-chr3:25025962..25028034,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9857350 | chr3:25025216-25025217 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs143212329 | chr3:25025235-25025236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144491212 | chr3:25025253-25025254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560904516 | chr3:25025277-25025278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190810749 | chr3:25025284-25025285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549849486 | chr3:25025352-25025353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563343493 | chr3:25025386-25025387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569759773 | chr3:25025388-25025389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538747458 | chr3:25025396-25025397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372847323 | chr3:25025411-25025412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552354334 | chr3:25025413-25025414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565761260 | chr3:25025436-25025437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534887110 | chr3:25025439-25025440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs118170397 | chr3:25025443-25025444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574706741 | chr3:25025523-25025524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537042520 | chr3:25025533-25025534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144406568 | chr3:25025555-25025556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148763101 | chr3:25025576-25025577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142412696 | chr3:25025588-25025589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111970959 | chr3:25025592-25025593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182585910 | chr3:25025593-25025594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573373408 | chr3:25025625-25025626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542443114 | chr3:25025653-25025654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386659433 | chr3:25025659-25025660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536190425 | chr3:25025676-25025677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562222401 | chr3:25025689-25025690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187292155 | chr3:25025694-25025695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12636044 | chr3:25025695-25025696 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs73143050 | chr3:25025756-25025757 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs532219839 | chr3:25025757-25025758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575828764 | chr3:25025813-25025814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12636070 | chr3:25025832-25025833 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs370336215 | chr3:25025853-25025854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565804496 | chr3:25025868-25025869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150945212 | chr3:25025873-25025874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190298620 | chr3:25025877-25025878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140775425 | chr3:25025878-25025879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13071983 | chr3:25025886-25025887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374673741 | chr3:25025887-25025888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556886861 | chr3:25025901-25025902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570533012 | chr3:25025915-25025916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77223018 | chr3:25025937-25025938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs13072583 | chr3:25025949-25025950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553174859 | chr3:25025966-25025967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573313916 | chr3:25025968-25025969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542048970 | chr3:25025975-25025976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555937904 | chr3:25026017-25026018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575962759 | chr3:25026020-25026021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182366720 | chr3:25026023-25026024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544943722 | chr3:25026024-25026025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:25025200-25027200 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr3:25027200-25027400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:25027200-25027400 | Enhancers | Fetal Muscle Leg | muscle |